/ EMR
Emerson (EMR) Reports Q4 Results with Revenue Slightly Below Estimates
Emerson’s Q4 2025 results showed steady growth, with EPS meeting expectations and revenue slightly below estimates.
November 05, 2025Emerson’s $1.48 EPS Beats Expectations in Q4 FY 2025, $4.62B in Revenue
Emerson's fourth-quarter performance showcased robust growth, with a 13% increase in net sales.
November 05, 2024